$USAC

USA Compression Partners (NYSE:USAC) Sets New 12-Month High on Analyst Upgrade

USA Compression Partners (NYSE:USAC) reached a new 52-week high after Texas Capital upgraded the stock from "Hold" to "Strong Buy". Trading volume was 48,768 shares, with the stock closing at $28.0140. Despite the upgrade, analyst sentiment is mixed, with an average price target of $26.67, below the current trading level, and the company's dividend payout ratio is 250%.

Original reporting
MarketBeat · MarketBeat
Published Mar 11, 2026, 4:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 11, 2026, 5:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
USA Compression Partners (NYSE:USAC) Sets New 12-Month High on Analyst Upgrade — source image
Decision brief

The 30-second read

$USACBullishMed
01

Why it matters

The upgrade and new high could attract short-term trading activity, but fundamental concerns like dividend payout ratio should be considered.

02

Market read

The news is relevant for traders focusing on energy transportation and midstream energy companies, especially those with recent analyst activity.

03

What to watch

Potential risks include dividend sustainability issues, sector-wide downturns, or broader market corrections that could negate recent gains.

Timing: short-term (next 1-4 weeks)

Background

USA Compression Partners is a midstream energy services company specializing in natural gas compression, with recent analyst upgrades signaling confidence.

Company-level read

Ticker impact

$USACBullishMedium confidence
Context

The news highlights a recent analyst upgrade and a new 12-month high, indicating potential short-term positive momentum.

Expected impact

Moderate upward price movement in the short term, possibly 3-5% over the next 2-4 weeks.

Evidence & confidence

The analyst upgrade and new high indicate positive sentiment; however, conflicting analyst price targets below current price and high dividend payout ratio introduce caution.

$USACNeutralMedium confidence
Context

The stock's relevance score is high (1.0), indicating significant impact from recent news, but the mixed analyst sentiment and high dividend payout ratio temper the overall bullishness.

Expected impact

Potential for short-term gains, but risk of correction exists due to conflicting signals.

Evidence & confidence

The recent upgrade and new high support positive momentum; however, analyst price targets below current price and dividend payout ratio indicate potential risks.

Market effects

The energy transportation sector may experience increased investor interest due to positive sentiment around USAC.

Limited regional impact; primarily relevant to US-based energy transport companies.

Low; the news pertains to a specific US company within a niche sector.

Counterpoint

The recent high and analyst upgrade may be short-lived; the stock could face a correction due to high dividend payout ratio and analyst targets below current price.

Key entities

  • USA Compression Partners

    A provider of natural gas compression services in the energy sector.

  • Texas Capital

    The firm that upgraded USAC from 'Hold' to 'Strong Buy'.

Related articles

$USACMed

USA Compression Partners Q2 Earnings Call Highlights

USA Compression Partners (NYSE:USAC) reported Q2 metrics including 4.95 million total fleet horsepower, 92% utilization, and average revenue per revenue-generating horsepower per month of $22.84. Adjusted gross margin was 63.5% and leverage was 3.72x. The firm reaffirmed 2026 outlook for adjusted EBITDA $770m-$800m and distributable cash flow $480m-$510m, plus capex guidance.

$USACMed

USA Compression Partners, LP (USAC): Results of Operations and Financial Condition

USA Compression Partners, LP (USAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 usacq22026ex991.htm EX-99.1 Document Exhibit 99.1 News Release USA Compression Partners, LP 8115 Preston Road, Suite 700 Dallas, Texas 75225 usacompression.com USA Compression Partners Reports Second-Quarter 2026 Results DALLAS, Texas, August 4, 2026 — USA Compression P

$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.